Foresite Capital

Foresite Technology Solutions Partners with Building Media Inc. to Expand Digital Training for Construction Labor Force

Retrieved on: 
Tuesday, September 6, 2022
Partnership, Workforce, BMI, CEO, Safety, Technology, Solution, Foresite Capital, Insurrection Media, Inc., Software, Learning, Curriculum, Software as a service, LLC, Quality control, Specialization, Risk, Face, Intellectual property, Industry, Efficiency, Construction

COSTA MESA, Calif., Sept. 6, 2022 /PRNewswire/ -- Foresite Technology Solutions, LLC, a Software-as-a-Service (SaaS) company, today announced a partnership with Building Media Inc., a company established to improve education opportunities for the construction community.

Key Points: 
  • COSTA MESA, Calif., Sept. 6, 2022 /PRNewswire/ --Foresite Technology Solutions, LLC, a Software-as-a-Service (SaaS) company, today announced a partnership with Building Media Inc., a company established to improve education opportunities for the construction community.
  • With increased access to intuitive training materials, Foresite further distances themselves from their competition.
  • The ability to continuously develop skills is essential and leads to better retention rates and more prosperous career opportunities down the road.
  • Building Media is proud to be a part of this cutting edge program to help educate the trades and drive efficiencies."

Mirvie Expands Leadership Team with Appointment of Alison Cowan, M.D. as Head of Medical Affairs

Retrieved on: 
Tuesday, August 30, 2022
FDA, Other Health, Pharmaceutical, General Health, Women, Medical Devices, Genetics, Parenting, Children, Baby, Maternity, Family, Biotechnology, Science, Consumer, Research, Health, Machine learning, Health equity, CEO, CFRNA, RNA, Ectopic pregnancy, Research, Medical Affairs Bureau, Food and Drug Administration, Emory University, Entrepreneurship, Disease, American Journal of Obstetrics and Gynecology, Placenta, General Catalyst, Parent, Food, Northwestern University, Supplement, Infant, GV, Pre-eclampsia, Obstetrics, Multimedia, Khosla Ventures, Biology, Foresite Capital, FDA, Blue Cross Blue Shield Association, Leadership, History, Preterm birth, American Journal, Woman, Health, Pregnancy, Patient, Birth control, Medicine, Nature, Ephraim Mirvis, Gynaecology

Mirvie , a pioneer in predicting unexpected pregnancy complications, today announced the appointment of Alison Cowan, M.D., M.S.C.R.

Key Points: 
  • Mirvie , a pioneer in predicting unexpected pregnancy complications, today announced the appointment of Alison Cowan, M.D., M.S.C.R.
  • View the full release here: https://www.businesswire.com/news/home/20220830005185/en/
    As a practicing OB/GYN, Dr. Cowan brings rigorous clinical experience to our fast-growing team, said Maneesh Jain, Co-Founder and CEO of Mirvie.
  • She received her medical degree and masters in clinical research from Emory University and conducted her OB/GYN residency at Northwestern University.
  • The team at Mirvie is addressing a staggering unmet need, as 1 in 5 pregnancies are impacted by complications,[3]said Dr. Cowan.

XinThera Mourns Loss of Founder Stephen Kaldor

Retrieved on: 
Monday, August 22, 2022
CA, Columbia University, CEO, BMS, McNerney, SAN, NASDAQ, Crown Bioscience International, KNTE, Board, Chemistry, CSO, Eli Lilly, Partner, Harvard University, Foresite Capital, Takeda, Board of directors, Doctor of Philosophy, Acquisition, Management, Pharmaceutical industry

SAN DIEGO, Aug. 22, 2022 /PRNewswire-PRWeb/ -- XinThera, Inc., today announced that Stephen Kaldor, Ph.D., its founder and chairman of its Board of Directors, passed away on August 8, 2022.

Key Points: 
  • "We've lost a great leader, friend and mentor"
    SAN DIEGO, Aug. 22, 2022 /PRNewswire-PRWeb/ --XinThera, Inc., today announced that Stephen Kaldor, Ph.D., its founder and chairman of its Board of Directors, passed away on August 8, 2022.
  • "We've lost a great leader, friend and mentor," said Qing Dong, XinThera's co-founder, president and CSO.
  • "XinThera was a very important part of Steve's distinguished career in the biotech industry.
  • XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline based in San Diego, CA.

Foresite Labs Appoints Uplaksh Kumar, Former GRAIL and Verily Operations Lead, to Chief Operating Officer

Retrieved on: 
Wednesday, August 17, 2022
Science, Other Science, Biotechnology, Research, Health, Data Management, Health Technology, Technology, CEO, SVP, B cell, Investment, Regenerative medicine, History of the University of Maryland, College Park, Foresite Capital, University, Research, Data science, BD, GRAIL, COO, CSO, CTO, Life Technologies, Science, Verily, Pharmacy, Labs, IPO, Disease, Management, Fine chemical, Pharmaceutical industry, Qiagen, Science Gallery

Foresite Labs today announced the appointment of Uplaksh Kumar as its chief operating officer (COO).

Key Points: 
  • Foresite Labs today announced the appointment of Uplaksh Kumar as its chief operating officer (COO).
  • Prior to joining Foresite Labs, Uplaksh Kumar was the SVP of strategic operations and scale at GRAIL , where he launched the Galleri test, a multi-cancer early detection test.
  • Kumar will focus on leading the operations functions for Foresite Labs and efficiently scaling Foresite Labs incubated companies.
  • It also comes after Foresite Capital's latest announcement of $173 million raised to invest in Foresite Labs funded companies.

Foresite Technology Solutions Partners with Lilt to Break Down Language Barriers in the Construction Industry

Retrieved on: 
Monday, July 25, 2022
Learning, American Council, American Council on the Teaching of Foreign Languages, Foresite Capital, Education, CEO, Quality control, Translation, Intellectual property, Construction, Partnership, Software, Workforce, UiPath, Risk, Safety, Language, Organization, Technology, Foreign, Software as a service, Efficiency, Face, LLC, Automation, Emerson, AI, Intel, Video game, Online shopping, ASICS, Lilt

COSTA MESA, Calif., July 25, 2022 /PRNewswire/ -- Foresite Technology Solutions, LLC, a Software-as-a-Service (SaaS) construction company, today announced a partnership with Lilt, the leading global experience platform, to integrate multilingual content into Foresite's platform for increased accessibility and improved Foresite user experience.

Key Points: 
  • With this new capability, Foresite seeks to eliminate the barriers that foreign language can have in communication-based safety issues in construction.
  • With the integration of Lilt, Foresite incorporates cost-effective multilingual content to support its efforts to break down language barriers, an imperative software capability in the construction industry.
  • "Our partnership with Lilt highlights how we use leading technology partners, such as Lilt, to improve the construction industry labor force with multilingualupskilling content.
  • "Foresite recognizes that the elimination of language barriers reduces risk, increases safety, and empowers employees," said Spence Green, CEO of Lilt.

Foresite Technology Solutions Secures $8M in Financing to Launch its Construction Platform

Retrieved on: 
Thursday, June 30, 2022
Efficiency, Workplace, Construction, Solution, CEO, Technology, Workforce, Growth, Industry, Intellectual property, Compliance, LLC, Quality control, Artificial intelligence, Gallant, Safety, Q3, Foresite Capital

COSTA MESA, Calif., June 30, 2022 /PRNewswire/ -- Foresite Technology Solutions, LLC (Foresite), a technology company focused on the construction industry, announced $8 million in financing in a funding round led by Gallant Capital. The funding will be used to deploy Foresite's construction platform to support builders and trades in driving efficiencies, safety, quality, training and regulatory compliance directly at the jobsite. 

Key Points: 
  • The platform, which will launch in Q3, increases profitability for builders and trade contractors through innovation at the jobsite
    COSTA MESA, Calif., June 30, 2022 /PRNewswire/ --Foresite Technology Solutions, LLC (Foresite), a technology company focused on the construction industry, announced $8 million in financing in a funding round led by Gallant Capital.
  • The platform replaces numerous manual processes and siloed technology applications while reducing inefficiencies and cost over-runs, resulting in builders and trades having an unprecedented control over project profitability.
  • Foresite, which was founded in June, 2021, will deploy its flagship product in the third quarter of 2022.
  • Foresite is an innovative and transformative construction platform built on 25 years of intellectual property and industry knowledge.

Quantum-Si Appoints Vikram Bajaj, Ph.D., to Board of Directors

Retrieved on: 
Thursday, June 16, 2022
Science, Biotechnology, Research, Pharmaceutical, Health, Medical Devices, Technology, Semiconductor, UC Berkeley College of Chemistry, Berkeley, Verily, Military, College, R, Department, COVID-19, Lawrence Berkeley National Laboratory, Risk, GRAIL, Bajaj, Technology, Defense, Nasdaq, Company, Coronavirus Scientific Advisory Board (Turkey), Precision medicine, Proteomics, Humanitarian use licenses, Stanford University School of Medicine, Massachusetts Institute of Technology, Science, Private Securities Litigation Reform Act, Engineering, Growth, DNA, Drug discovery, Marketing, Interim, University, Chinese Academy of Sciences, Investment, SEC, Partnership, Foresite Capital, Board of directors, Doctor of Philosophy, Board, Management, Biology

Prior to joining Foresite Capital, Vik was the Chief Scientific Officer of GRAIL and remains on its Scientific Advisory Board.

Key Points: 
  • Prior to joining Foresite Capital, Vik was the Chief Scientific Officer of GRAIL and remains on its Scientific Advisory Board.
  • He is also the co-founder and former Chief Scientific Officer of Verily (formerly Google Life Sciences) and served as chair of its Scientific Advisory Board.
  • He is an advisor to the Department of Defense through the Defense Science Boards Task Force on Biology.
  • Vik is a trailblazer in the field of precision medicine and brings decades of expertise as a scientist and entrepreneur.

Foresite Cybersecurity Announces Pivot to Open XDR and Compliance Platform

Retrieved on: 
Wednesday, June 1, 2022
Product management, XDR, CEO, Policy, FIRM, Foresite Capital, Provision, Organization, Multimedia, Intelligence, EDR, Machine learning, Risk, Compliance, Industry, NDR, Software as a service, Data science, Medical device, Risk management, Online shopping

OVERLAND PARK, Kan., June 1, 2022 /PRNewswire/ -- Foresite Cybersecurity, an industry leader in cybersecurity and compliance, announced today it is shifting direction from tech-enabled services to a product-led Open XDR SaaS platform. The platform will offer a unique advantage for mid-market organizations to combine security data from a variety of sources into a singular location to gain a complete picture of their security and policy compliance maturity.

Key Points: 
  • OVERLAND PARK, Kan., June 1, 2022 /PRNewswire/ -- Foresite Cybersecurity, an industry leader in cybersecurity and compliance, announced today it is shifting direction from tech-enabled services to a product-led Open XDR SaaS platform.
  • What makes ProVision Open XDR unique:
    Integrated risk and compliance software to automatically align policies, practices, and technologies to continuously track risk and security maturity against 260+ compliance standards
    In addition to the clarity and insight provided by the ProVision Open XDR platform, Foresite Cybersecurity allows customers to view a quantifiable risk score with Foresite Integrated Risk Management (FIRM) .
  • To learn more about the ProVision Open XDR platform, FIRM, and the newest platform capabilities, request a demo or visit www.foresite.com .
  • Foresite Cybersecurity is an innovation-led cybersecurity as a service company offering an Open XDR security platform with best-in-class automated compliance software and concierge consulting to help organizations to reach and maintain their security and compliance goals.

Mirvie Raises $60 Million Funding Round to Shape the Future of Pregnancy Health

Retrieved on: 
Tuesday, May 17, 2022
Nursing, Women, Other Science, FDA, Technology, Research, Diabetes, Family, Other Health, Consumer, Parenting, Medical Devices, Baby, Maternity, Hospitals, Genetics, Clinical Trials, Other Technology, Biotechnology, Health, Science, Health, History, Disease, Doctor of Philosophy, Food, Supplement, Placenta, Patient, Biology, Woman, Parent, GV, American Journal of Obstetrics and Gynecology, Foresite Capital, General Catalyst, Research, FDA, Obstetrics, Food and Drug Administration, Awareness, BlackRock, Comerica, RNA, Pregnancy, Ectopic pregnancy, American Journal, CFRNA, Machine learning, Preterm birth, Pre-eclampsia, Khosla Ventures, Entrepreneurship, CEO, Birth control, Health insurance, Ephraim Mirvis, Nature, Gynaecology

[1],[2] Peer-reviewed, clinical evidence shows this breakthrough has the power to transform how we detect, prevent, and treat pregnancy complications.

Key Points: 
  • [1],[2] Peer-reviewed, clinical evidence shows this breakthrough has the power to transform how we detect, prevent, and treat pregnancy complications.
  • At Mirvie, we find it unacceptable that pregnancy health has not advanced meaningfully in decades, said Maneesh Jain, Co-Founder and CEO of Mirvie.
  • We believe the Mirvie RNA platform can shape a new future of predictive, preventive, and personalized pregnancy care for the well-being of millions of expecting parents and babies.
  • Mirvie is shaping the future of pregnancy health by providing women, expecting parents and their doctors with an early detection window to intervene before unexpected pregnancy complications become a crisis.

Kriya Announces $270 Million Series C Financing to Advance Fully Integrated Gene Therapy Engine

Retrieved on: 
Monday, May 16, 2022
Biotechnology, Pharmaceutical, Genetics, Health, Engineering, R, GMP, Cloud computing, Therapy, Foresite Capital, Architecture, Conditional sentence, Technology, Ecosystem, Triangle Park (Quezon City), LinkedIn, QVT, Entrepreneurship, Growth, Pharmaceutical industry, Medical device, Kriyā, Ophthalmology

Kriya Therapeutics, Inc. , a fully integrated gene therapy company pioneering novel technologies and therapeutics, today announced a $270 Million Series C financing.

Key Points: 
  • Kriya Therapeutics, Inc. , a fully integrated gene therapy company pioneering novel technologies and therapeutics, today announced a $270 Million Series C financing.
  • Proceeds from this financing will support the advancement of Kriyas pipeline and continued scaling of its engineering, manufacturing, and computational platforms.
  • Kriya has established an ecosystem for delivering best-in-class technologies and medicines in gene therapy, with core business units in technology, manufacturing, R&D, and therapeutics.
  • Kriya is a fully integrated gene therapy company on a mission to revolutionize how gene therapies are designed, developed, and manufactured with a goal of improving speed to market and reducing cost.